On 2025-05-15, Elevation Oncology, Inc. (ELEV) announced earnings per share of $-0.24 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-0.20.
The next expected annoucement date for quarterly earnings is 2025-08-05, with an average estimated earnings per share of $-0.26 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
---|---|---|---|
2025-05-15 | 2025-03-31 | $-0.20 | $-0.24 |
2025-03-06 | 2024-12-31 | $-0.22 | $-0.18 |
2024-11-06 | 2024-09-30 | $-0.20 | $-0.22 |
2024-08-06 | 2024-06-30 | $-0.23 | $-0.18 |
2024-05-02 | 2024-03-31 | $-0.21 | $-0.23 |
2024-03-06 | 2023-12-31 | $-0.21 | $-0.19 |
2023-11-02 | 2023-09-30 | $-0.34 | $-0.25 |
2023-08-03 | 2023-06-30 | $-0.28 | $-0.37 |
2023-05-15 | 2023-03-31 | $-0.51 | $-0.50 |
2023-03-09 | 2022-12-31 | $-0.67 | $-0.82 |
2022-11-03 | 2022-09-30 | $-1.12 | $-1.67 |
2022-08-04 | 2022-06-30 | $-0.80 | $-0.86 |
2022-05-05 | 2022-03-31 | $-0.51 | $-0.74 |
2022-03-03 | 2021-12-31 | $-0.59 | $-0.41 |
2021-11-12 | 2021-09-30 | $-0.35 | $-0.53 |
2021-08-12 | 2021-06-30 | $-2.51 | $-4.84 |